NewsEpisurf Medical has become an approved supplier to Spire Healthcare, one of the UK’s largest independent hospital providers

Episurf Medical (NASDAQ: EPIS B) has become an approved supplier to Spire Healthcare, one of the UK’s largest independent hospital providers with 39 hospitals, 10 clinics and two specialist cancer care centres across England, Wales and Scotland. The decision has been made following a review process.

“We are very pleased that, with the support from some of the UK’s leading surgeons, Episealer® has received approval from Spire Healthcare as a new treatment method for focal cartilage and bone damages of the knee”, says Pål Ryfors, CEO Episurf Medical. “Spire Healthcare delivers a very high standard of care for both private and NHS patients across the UK. We look forward to offering the Episealer® to suitable patients, enabling them to benefit from our technology which can help them to get back to a pain-free lifestyle”, concludes Ryfors.

For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel: +46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com